Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism (Q42741021)

6 November 2017

title

Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism (English)

1 reference

6 November 2017

1 reference

1 reference

Yasuo Imanishi

1

1 reference

6 November 2017

Takehisa Kawata

2

1 reference

6 November 2017

Takao Kenko

3

1 reference

6 November 2017

Michihito Wada

4

1 reference

6 November 2017

Nobuo Nagano

5

1 reference

6 November 2017

Takami Miki

6

1 reference

6 November 2017

Andrew Arnold

7

1 reference

6 November 2017

Masaaki Inaba

8

1 reference

6 November 2017

language of work or name

English

0 references

publication date

4 May 2011

1 reference

Calcified Tissue International

6 November 2017

published in

1 reference

6 November 2017

volume

89

1 reference

6 November 2017

issue

1

1 reference

6 November 2017

page(s)

29-35

1 reference

A novel cyclin encoded by a bcl1-linked candidate oncogene

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Positional cloning of the gene for multiple endocrine neoplasia-type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Animal models of hyperfunctioning parathyroid diseases for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Cinacalcet in hyperfunctioning parathyroid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Vitamin D-independent therapeutic effects of extracellular calcium in a mouse model of adult-onset secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9490-4

10.1007/S00223-011-9490-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 November 2017

1007216343

0 references

1 reference